tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

LLY Stock Latest News

Tariffs Weigh on Eli Lilly Stock (LLY) Ahead of Earnings
Market NewsTariffs Weigh on Eli Lilly Stock (LLY) Ahead of Earnings
4h ago
LLY
Eli Lilly’s Promising Study: Combining Ixekizumab and Tirzepatide for Psoriasis and Weight Management
PremiumCompany Announcements
Eli Lilly’s Promising Study: Combining Ixekizumab and Tirzepatide for Psoriasis and Weight Management
6h ago
LLY
Eli Lilly’s Orforglipron Study: A New Hope for Sleep Apnea Treatment?
PremiumCompany Announcements
Eli Lilly’s Orforglipron Study: A New Hope for Sleep Apnea Treatment?
6h ago
LLY
Eli Lilly’s Retatrutide Study: A Potential Game-Changer in Obesity Treatment
PremiumCompany Announcements
Eli Lilly’s Retatrutide Study: A Potential Game-Changer in Obesity Treatment
6h ago
LLY
Eli Lilly’s Tirzepatide Study: A New Hope for Adolescent Obesity?
PremiumCompany Announcements
Eli Lilly’s Tirzepatide Study: A New Hope for Adolescent Obesity?
6h ago
LLY
Eli Lilly’s Alzheimer’s Study: A Potential Game-Changer in Treatment
PremiumCompany AnnouncementsEli Lilly’s Alzheimer’s Study: A Potential Game-Changer in Treatment
6h ago
LLY
Eli Lilly and AstraZeneca’s Promising Phase 3 Trial for KRAS G12C-Mutant NSCLC
Premium
Company Announcements
Eli Lilly and AstraZeneca’s Promising Phase 3 Trial for KRAS G12C-Mutant NSCLC
6h ago
AZN
LLY
Eli Lilly’s New Study on Weight Management Drugs: Potential Market Impact
Premium
Company Announcements
Eli Lilly’s New Study on Weight Management Drugs: Potential Market Impact
6h ago
LLY
Eli Lilly’s Retatrutide Study: A Step Forward in Obesity Treatment
PremiumCompany Announcements
Eli Lilly’s Retatrutide Study: A Step Forward in Obesity Treatment
6h ago
LLY
Eli Lilly’s New Study on LY3848575: A Potential Game-Changer in Neuropathic Pain Treatment
PremiumCompany Announcements
Eli Lilly’s New Study on LY3848575: A Potential Game-Changer in Neuropathic Pain Treatment
6h ago
LLY
Eli Lilly’s New Study on Mirikizumab and Tirzepatide: What Investors Need to Know
PremiumCompany Announcements
Eli Lilly’s New Study on Mirikizumab and Tirzepatide: What Investors Need to Know
6h ago
LLY
Eli Lilly’s New Study on LY4066708: A Potential Game-Changer?
PremiumCompany Announcements
Eli Lilly’s New Study on LY4066708: A Potential Game-Changer?
6h ago
LLY
Eli Lilly’s Mirikizumab Study: A Potential Game-Changer for Pediatric Ulcerative Colitis and Crohn’s Disease
PremiumCompany AnnouncementsEli Lilly’s Mirikizumab Study: A Potential Game-Changer for Pediatric Ulcerative Colitis and Crohn’s Disease
6h ago
LLY
Eli Lilly’s Innovative Study on Remternetug Delivery Methods
Premium
Company Announcements
Eli Lilly’s Innovative Study on Remternetug Delivery Methods
6h ago
LLY
Eli Lilly’s SURPASS-CVOT Study: A Potential Game-Changer in Diabetes Treatment
Premium
Company Announcements
Eli Lilly’s SURPASS-CVOT Study: A Potential Game-Changer in Diabetes Treatment
6h ago
LLY
Eli Lilly’s Phase 3 Breast Cancer Study: A Potential Game-Changer?
PremiumCompany Announcements
Eli Lilly’s Phase 3 Breast Cancer Study: A Potential Game-Changer?
6h ago
LLY
Eli Lilly’s Innovative Approach to Liver Disease: A Study Update
PremiumCompany Announcements
Eli Lilly’s Innovative Approach to Liver Disease: A Study Update
6h ago
LLY
Eli Lilly’s Phase 2 Study on LY2784544: A Potential Game-Changer for Myeloproliferative Neoplasms
PremiumCompany Announcements
Eli Lilly’s Phase 2 Study on LY2784544: A Potential Game-Changer for Myeloproliferative Neoplasms
6h ago
LLY
Eli Lilly’s Promising Diabetes Study: Retatrutide in Focus
PremiumCompany Announcements
Eli Lilly’s Promising Diabetes Study: Retatrutide in Focus
6h ago
LLY
Eli Lilly’s New Study on LY4086940: A Potential Game-Changer for Obesity and Diabetes?
PremiumCompany AnnouncementsEli Lilly’s New Study on LY4086940: A Potential Game-Changer for Obesity and Diabetes?
6h ago
LLY
Eli Lilly’s Lebrikizumab Trial: A Potential Game-Changer for Atopic Dermatitis Treatment
Premium
Company Announcements
Eli Lilly’s Lebrikizumab Trial: A Potential Game-Changer for Atopic Dermatitis Treatment
6h ago
LLY
Eli Lilly’s New Drug Study: What Investors Need to Know
Premium
Company Announcements
Eli Lilly’s New Drug Study: What Investors Need to Know
6h ago
LLY

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >